You are here

Article info

Article menu

Download PDFPDF

Research Article
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
Free

Authors

  • André P Fay Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Programa de Pós-Graduação em Medicina e Ciências da Saúde, Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul Av. Ipiranga 6690 90619-900 Porto Alegre RS Brazil PubMed articlesGoogle scholar articles
  • Sabina Signoretti Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA PubMed articlesGoogle scholar articles
  • Marcella Callea Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Gabriela H Telό Joslin Diabetes Center One Joslin Place 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Rana R McKay Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA PubMed articlesGoogle scholar articles
  • Jiaxi Song Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Ingrid Carvo Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Megan E Lampron Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Marina D Kaymakcalan Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Carlos E Poli-de-Figueiredo Programa de Pós-Graduação em Medicina e Ciências da Saúde, Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul Av. Ipiranga 6690 90619-900 Porto Alegre RS Brazil PubMed articlesGoogle scholar articles
  • Joaquim Bellmunt Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA PubMed articlesGoogle scholar articles
  • F Stephen Hodi Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA Center of Immuno-Oncology 450 Brookline Avenue 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Gordon J Freeman Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA PubMed articlesGoogle scholar articles
  • Aymen Elfiky Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA PubMed articlesGoogle scholar articles
  • Toni K Choueiri Dana-Farber Cancer Institute 450 Brookline Avenue (DANA 1230) 02215 Boston MA USA Brigham and Women’s Hospital 75 Francis Street (Thorn Building 504A) 02215 Boston MA USA Harvard Medical School 25 Shattuck Street 02115 Boston MA USA PubMed articlesGoogle scholar articles
  1. ↵a Andre_Fay{at}dfci.harvard.edu
  2. ↵b ssignoretti{at}partners.org
  3. ↵c calleamarcella{at}hotmail.it
  4. ↵d gabrielatelo{at}yahoo.com.br
  5. ↵e Rana_Mckay{at}dfci.harvard.edu
  6. ↵f jsong0{at}partners.org
  7. ↵g icarvo{at}partners.org
  8. ↵h MeganE.Lampron{at}gmail.com
  9. ↵i Marina_Kaymakcalan{at}dfci.harvard.edu
  10. ↵j cepolif{at}pucrs.br
  11. ↵k Joaquim_Bellmunt{at}dfci.harvard.edu
  12. ↵l Stephen_Hodi{at}dfci.harvard.edu
  13. ↵m Gordon_Freeman{at}dfci.harvard.edu
  14. ↵n Aymen_Elfiky{at}dfci.harvard.edu
  15. ↵o toni_choueiri{at}dfci.harvard.edu
View Full Text

Citation

Fay AP, Signoretti S, Callea M, et al
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
Journal for ImmunoTherapy of Cancer 2015;3:3. doi: 10.1186/s40425-015-0047-3

Publication history

  • Received November 14, 2014
  • Accepted January 17, 2015
  • First published February 17, 2015.
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2015